157 related articles for article (PubMed ID: 7132675)
21. Influence of drug treatment on glucocorticoid receptor levels in patients with coronary heart disease.
Ji H; Guo WZ; Yan ZH; Li D; Lu CL
Chin Med J (Engl); 2010 Jul; 123(13):1685-9. PubMed ID: 20819629
[TBL] [Abstract][Full Text] [Related]
22. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug.
Straka RJ; Fish JT; Benson SR; Suh JT
Pharmacotherapy; 1997; 17(1):126-32. PubMed ID: 9017773
[TBL] [Abstract][Full Text] [Related]
23. [Isosorbide dinitrate spray: a comparative pharmacodynamic study with a sublingual preparation in patients with chronic cardiac insufficiency].
Marchionni N; Di Bari M; Ferrucci L; Moschi G; Paoletti M; Salani B; Boncinelli L; Fumagalli S; Schneeweiss A
Cardiologia; 1988 May; 33(5):505-9. PubMed ID: 3048661
[No Abstract] [Full Text] [Related]
24. [Effect of isosorbide dinitrate on the blood circulation system in patients with ischemic heart disease].
Gaponenko VA; Santova RA; Chilikina ON; Akhmetova MG; Moskalenko NP; Glezer GA
Ross Med Zh; 1992; (4):45-7. PubMed ID: 1521022
[No Abstract] [Full Text] [Related]
25. [Comparative ergometric tests in coronary disease patients under betasympathicolysis using Betadrenol and Isoket].
Raff U; Jeschke D
Med Welt; 1977 Sep; 28(38):1518-21. PubMed ID: 20547
[No Abstract] [Full Text] [Related]
26. [Effects of sublingual isosorbide dinitrate on systolic time intervals in normal subjects and those with coronary disease].
Paterna S; Campisi D; Bivona A; Valenza M; Di Maso N; Alaimo V
Boll Soc Ital Biol Sper; 1984 Jan; 60(1):29-35. PubMed ID: 6704251
[TBL] [Abstract][Full Text] [Related]
27. Antianginal effect of nifedipine in patients with ischemic heart disease.
Hernandez-Pieretti O; Urbina-Quintana A; de Hernandez MI; de Rojas E; Velasco M
Curr Ther Res Clin Exp; 1976 Jan; 19(1):39-42. PubMed ID: 812663
[No Abstract] [Full Text] [Related]
28. [Effectiveness of nifedipine, a calcium antagonist, on the ECG aspects of ischemic myocardiopathy].
Alfano G; Melandri F; Moracchini PV; De Gesu R; Boschi S
Boll Soc Ital Cardiol; 1978; 23(8):1394-401. PubMed ID: 549625
[No Abstract] [Full Text] [Related]
29. [Clinical evaluation of isosorbitol dinitrate (isosorbide dinitrate) in patients with critical stenosis of coronary arteries].
Podolec P; Pieniazek P; Badacz L; Tracz W
Pol Tyg Lek; 1984 Jan; 39(1):13-5. PubMed ID: 6377276
[No Abstract] [Full Text] [Related]
30. [Effect of isosorbide dinitrate on neutrophil migration in vivo].
Wysocki H; Siminiak T; Szczepanik A
Kardiol Pol; 1989; 32(5):255-8. PubMed ID: 2699625
[TBL] [Abstract][Full Text] [Related]
31. [Initial experience. Comparative study of verapamil and nifedipine in the treatment of coronary insufficiency. Evaluation by a cycloergometric test].
Figueira RH; Guimarães F; Wagner M; Bozza AE; Dohmann HJ
Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():39-43. PubMed ID: 354612
[No Abstract] [Full Text] [Related]
32. [Preliminary clinical evaluation of the use of nifedipine].
De Pasquale B; Bossa P
Boll Soc Ital Cardiol; 1978; 23(10):1735-7. PubMed ID: 261837
[No Abstract] [Full Text] [Related]
33. [A control trial of flavonoids of Hippophae rhamnoides L. in treating ischemic heart disease].
Zhang MS
Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Apr; 15(2):97-9. PubMed ID: 3304921
[No Abstract] [Full Text] [Related]
34. [Results of a field trial of the coronary drug Adalat (BAY a 1040)].
Dünschede HB; Grundei P
Med Welt; 1975 Oct; 26(40):1847-50. PubMed ID: 1102835
[No Abstract] [Full Text] [Related]
35. [Action of nifedipine on the response to exertion and on peripheral tissue oxygenation. Comparative study of healthy individuals and coronary insufficiency patients].
Botas L; Freitas JP; Barroca JP; Proenca C; Pereira JM; Martins e Silva JA
Rev Esp Cardiol; 1982; 35(5 Suppl 2):II75-81. PubMed ID: 6763270
[No Abstract] [Full Text] [Related]
36. [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)].
Philipp R; Kutscha W
Med Welt; 1980 May; 31(21):817-20. PubMed ID: 7392937
[No Abstract] [Full Text] [Related]
37. [Longterm effect and maintenance therapy with cutaneous isosorbide dinitrate in patients with coronary heart disease (author's transl)].
Brunner D; Weisbord J; Meshulam N; Margulis S
MMW Munch Med Wochenschr; 1980 May; 122(21):801-6. PubMed ID: 6771600
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Cocco G; Strozzi C; Chu D; Amrein R; Castagnoli E
Br J Clin Pract Suppl; 1980; 8():59-65. PubMed ID: 6781520
[No Abstract] [Full Text] [Related]
39. [Ergometric studies and clinical observations in patients with coronary disease treated with nifedipine].
Adamska-Dyniewska H; Atta W
Kardiol Pol; 1977; 20(2):107-13. PubMed ID: 864905
[No Abstract] [Full Text] [Related]
40. [Electrophysiological effects of nifedipine in humans. Preliminary note].
Disertori M; Molinis G; Antonini L; Furlanello F
Minerva Cardioangiol; 1978 Nov; 26(11):713-9. PubMed ID: 724117
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
